In your state
Nebraska

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Nebraska

$5.4B

Total output supported by biophamaceutical sector

$858,488

Total output supported by biophamaceutical sector

17,969

Total Jobs

3,246

Direct Jobs

Clinical Trials in Your State: Nebraska

403

TOTAL CLINICAL TRIALS

$153.2 million

INVESTED IN CLINICAL TRIALS

8,403

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$394.7 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: Nebraska

State programs and initiatives to promote biopharmaceutical industry development

    ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT

    BUILDING ADVANCED MANUFACTURING

    BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE

    ECONOMIC INNOVATION INCENTIVES

    STEM EDUCATION & WORKFORCE DEVELOPMENT

    TARGETED STRATEGIES

    VENTURE FINANCING

State Innovation Indicators

8

Patents per 1,000 people in Science & Engineering

6.5%

Percentage of Workforce Employed in High-Tech Jobs